{"id":14437,"date":"2022-12-16T08:03:00","date_gmt":"2022-12-16T08:03:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3964241_AE64241_0"},"modified":"2022-12-16T08:03:00","modified_gmt":"2022-12-16T08:03:00","slug":"possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=14437","title":{"rendered":"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia"},"content":{"rendered":"
\n\n\n\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

SINGAPORE<\/span><\/span>, Dec. 16, 2022<\/span><\/span> \/PRNewswire\/ — Neuome Peptides Pte. Ltd., a Singapore<\/span>-based company has established an assay-development platform<\/b>, powered by machine learning<\/b> and novel, patented algorithms<\/b> for the quantifiable<\/b> detection of biomarkers.<\/p>\n

\n

<\/a>
<\/span><\/p>\n<\/p><\/div>\n

The company successfully designed specific peptides<\/b> to bind to pre-established, proven biomarkers for Cardiovascular Diseases<\/b> and is currently developing effective diagnostic assays<\/b>. The use of small peptides, conjugated with gold nanoparticles, allows a balance of high specificity and sensitivity, giving highly accurate and fast results<\/b>.<\/p>\n

According to the World Heart Federation, cardiovascular disease accounts for nearly one third of all deaths in Southeast Asia<\/span><\/b>, killing 4 million people every year<\/b>. Therefore, frequent testing with enhanced diagnosis is required for preventive care.<\/p>\n

This is made possible with the product TruHeart\u2122<\/b>, a point-of-care assay to diagnose Acute Coronary Syndrome <\/b>that can give quantifiable<\/b> results within 3-5 minutes<\/b>, using a finger-prick<\/b> sample to test for the crucial<\/b> biomarkers, Troponins I and T<\/b>, and Myoglobin <\/b>(eventually expanding to D-Dimer <\/b>and Brain Natriuretic Peptide<\/b>). It is in the advanced stages of R&D and progressing to global clinical trials<\/b>. It will be submitted for FDA approval and then introduced to the market upon approval.<\/p>\n

This product could be a game-changer, allowing patients to affordably screen for this potentially deadly condition conveniently early, in their own home<\/b>, achieving quantifiable<\/b> results without needing a laboratory<\/b>. This more efficiently guides patients to seek appropriate medical attention; those with prevailing heart conditions may also regularly <\/b>monitor their condition at home<\/b>. In comparison to industry standards, it will be uniquely affordable<\/b>; its peptide-coated cartridges will cost only ~USD$2<\/span><\/b>, while the quantitative electronic reader will cost ~USD$80<\/span><\/b>. This is in contrast<\/b> to existing point-of-care devices also giving quantitative results for cardiac biomarkers, but at device costs of up to USD$4,500<\/span>, <\/b>with cartridges ranging from USD$18<\/span>-37<\/b>.<\/p>\n

The company’s Scientific Advisory Board includes prominent leaders in this field, such as Padmashri Balram Bhargava<\/span>,<\/b> former Director General Indian Council of Medical Research (ICMR). The company has scheduled clinical trials<\/b> in five hospitals in India<\/span> (including the renowned Narayana<\/b> Hrudayalaya<\/b>), in the process of securing a large site in the US and five sites in Europe<\/span>. It is also advanced discussions with A*Star<\/b> and Singapore’s<\/span> National Heart Centre.<\/b> This is only one of many pipeline products made possible by its patented method of peptide-design. The immediate pipeline includes assays for Prostate and Colorectal Cancers,<\/b> Dengue, Malaria, and more.<\/b><\/p>\n

About Neuome Peptides<\/b><\/p>\n

It specializes in using a peptide-based approach to disrupt and democratize the diagnostics industry with affordable devices, able to provide lab-quality results in a fraction of the time and at a fraction of the cost. In line with its motto, “Convergence of Science” that integrates elements of life sciences, nanotechnology, electronics, and AI\/machine learning in its products. The company’s mission is to develop accurate, efficient and affordable diagnostic solutions to prevalent global health issues.<\/p>\n

Learn more about TruHeart\u2122: https:\/\/neuomepeptides.com\/truheart\/<\/a><\/u><\/p>\n<\/p><\/div>\n

Source: Neuome Peptides Pte. Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"

SINGAPORE, Dec. 16, 2022 \/PRNewswire\/ — Neuome Peptides Pte. Ltd., a Singapore-based company has established an assay-development platform, powered by machine learning and novel, patented algorithms for the quantifiable detection of biomarkers. The company successfully designed specific peptides to bind to pre-established, proven biomarkers for Cardiovascular Diseases and is currently developing effective diagnostic assays. The […]<\/p>\n","protected":false},"author":8,"featured_media":14438,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-14437","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"\nPossible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=14437\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia - My Blog\" \/>\n<meta property=\"og:description\" content=\"SINGAPORE, Dec. 16, 2022 \/PRNewswire\/ — Neuome Peptides Pte. Ltd., a Singapore-based company has established an assay-development platform, powered by machine learning and novel, patented algorithms for the quantifiable detection of biomarkers. The company successfully designed specific peptides to bind to pre-established, proven biomarkers for Cardiovascular Diseases and is currently developing effective diagnostic assays. The […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=14437\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-16T08:03:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/1968342\/NeuomePeptides_newLogo__1_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia\",\"datePublished\":\"2022-12-16T08:03:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437\"},\"wordCount\":495,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437\",\"name\":\"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg\",\"datePublished\":\"2022-12-16T08:03:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg\",\"width\":599,\"height\":412},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=14437#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=14437","og_locale":"en_US","og_type":"article","og_title":"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia - My Blog","og_description":"SINGAPORE, Dec. 16, 2022 \/PRNewswire\/ — Neuome Peptides Pte. Ltd., a Singapore-based company has established an assay-development platform, powered by machine learning and novel, patented algorithms for the quantifiable detection of biomarkers. The company successfully designed specific peptides to bind to pre-established, proven biomarkers for Cardiovascular Diseases and is currently developing effective diagnostic assays. The […]","og_url":"https:\/\/transmediavictoria.net.au\/?p=14437","og_site_name":"My Blog","article_published_time":"2022-12-16T08:03:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/1968342\/NeuomePeptides_newLogo__1_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=14437#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=14437"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia","datePublished":"2022-12-16T08:03:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=14437"},"wordCount":495,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=14437#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/12\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=14437","url":"https:\/\/transmediavictoria.net.au\/?p=14437","name":"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=14437#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=14437#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/12\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg","datePublished":"2022-12-16T08:03:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=14437#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=14437"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=14437#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/12\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/12\/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia.jpg","width":599,"height":412},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=14437#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/14437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14437"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/14437\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/14438"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}